TABLE.
Characteristic | No. | (%) |
---|---|---|
Age group (yrs) | ||
≤19 | 1 | (3) |
20–64 | 24 | (77) |
≥65 | 4 | (13) |
Unknown | 2 | (6) |
Sex | ||
Female | 24 | (77) |
Male | 7 | (23) |
Body system/Organ affected * | ||
Neurologic | 21 | (68) |
Respiratory | 17 | (55) |
Gastrointestinal | 13 | (42) |
Other | 11 | (35) |
Skin | 7 | (23) |
Eye | 7 | (23) |
Case classification | ||
Possible | 30 | (97) |
Probable | 1 | (3) |
Severity of illness † | ||
Low | 26 | (84) |
Moderate | 5 | (16) |
Route of exposure § | ||
Respiratory | 28 | (90) |
Dermal | 5 | (16) |
Location of exposure | ||
Home | 24 | (77) |
Workplace (Store/Office) | 3 | (10) |
Other (Boat/Car) | 3 | (10) |
Unknown | 1 | (3) |
Label violation status | ||
Applied DDVP in areas occupied by humans ≥4 hours/day | 18 | (58) |
Excessive application | 2 | (6) |
Undetermined¶ | 11 | (35) |
Sum exceeds 100% because some patients had more than one affected body system/organ.
Low severity cases usually resolve without treatment and cause minimal time lost from work (<3 days). Moderate severity cases are not life threatening but require medical treatment and result in <6 days lost from work.
The sum exceeds 100% because two cases had both routes of exposure.
Insufficient data were available to determine whether the DDVP strip usage resulted in a label violation.